产品详情
简单介绍：
Anti-FRAT1抗体产品质量稳定，实验效果明显，货期快，价格优惠，欢迎垂询订购！我公司长期供应**组化抗体、WB抗体、**组化试剂盒和抗体试验所需全部相关试剂、荧光标记抗体、单克隆抗体、多克隆抗体、各种标记的二抗IgG/IgM/IgD/IgA等科研实验抗体。Anti-FRAT1抗体用于**组化实验,WB实验,相应的标记抗体有HRP标记抗体,FITC标记,BIO等。
详情介绍：
Rabbit Anti-FRAT1
Cat. Number:
Anti-FRAT1抗体KL-12434R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
FRAT1 and FRAT2 were originally characterized as proteins frequently rearranged in advanced T cell lymphoma, and they have since been identified as proto-oncogenes involved in tumorigenesis. These proteins share significantAnti-FRAT1抗体 homology with the Xenopus glycogen synthase kinase-3 (xGSK-3) binding protein, which is designated GBP and is essential for the formation of the dorsal-ventral axis during embryonic development. Establishment of these embryonic axes is mediated by the Wnt intracellular signaling pathway. Wnt signaling is regulated in part by the activity of GSK-3, which phosphorylates and thereby facilitates the degradation of ?catenin. GBP binds to GSK-3 and inhibits this phosphorylation, resulting in the accumulation of ?catenin and the subsequent transcription of Wnt target genes. Like GBP, FRAT2 has been shown to bind xGSK-3, suggesting that FRAT1 and FRAT2 may be GSK-3 regulatory proteins.
Also known as:
FRAT 1; frequently rearranged in advanced TAnti-FRAT1抗体 cell lymphomas; Frequently rearranged in advanced T-cell lymphomas; GSK 3 binding protein FRAT1; proto oncogene FRAT1; FRAT1_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Cow, .
●
Immunogen: KLH conjugated syntheticAnti-FRAT1抗体 peptide derived from human FRAT1.
●
Predicted Molecular Weight: 29kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-FRAT1抗体
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-FRAT1抗体
Optimal working dilutions must be determined by the end user.
kl726Ra01 转甲状腺素蛋白(TTR)多克隆抗体 Polyclonal Antibody to Transthyretin (TTR)
kl313Hu01 抗凝血酶(AT)多克隆抗体 Polyclonal Antibody to Antithrombin (AT)
kl313Mu01 抗凝血酶(AT)多克隆抗体 Polyclonal Antibody to Antithrombin (AT)
kl313Ra01 抗凝血酶(AT)多克隆抗体 Polyclonal Antibody to Antithrombin (AT)
kl820Hu01 凝血因子Ⅱ(F2)多克隆抗体 Polyclonal Antibody to Coagulation Factor II (F2)
kl820Mu01 凝血因子Ⅱ(F2)多克隆抗体 Polyclonal Antibody to Coagulation Factor II (F2)
kl820Ra01 凝血因子Ⅱ(F2)多克隆抗体 Polyclonal Antibody to Coagulation Factor II (F2)
kl353Ge01 晚期糖基化终末产物(AGE)多克隆抗体 Polyclonal Antibody to Advanced Glycation End Product (AGE)
kl929Hu01 视黄醇结合蛋白4(RBP4)多克隆抗体 Polyclonal Antibody to Retinol Binding Protein 4, Plasma (RBP4)
kl929Mu01 视黄醇结合蛋白4(RBP4)多克隆抗体 Polyclonal Antibody to Retinol Binding Protein 4, Plasma (RBP4)
kl929Ra01 视黄醇结合蛋白4(RBP4)多克隆抗体 Polyclonal Antibody to Retinol Binding Protein 4, Plasma (RBP4)
kl367Hu01 视黄醇结合蛋白3(RBP3)多克隆抗体 Polyclonal Antibody to Retinol Binding Protein 3, Interstitial (RBP3)
kl367Mu01 视黄醇结合蛋白3(RBP3)多克隆抗体 Polyclonal Antibody to Retinol Binding Protein 3, Interstitial (RBP3)
kl367Ra01 视黄醇结合蛋白3(RBP3)多克隆抗体 Polyclonal Antibody to Retinol Binding Protein 3, Interstitial (RBP3)
kl377Hu01 视黄醇结合蛋白2(RBP2)多克隆抗体 Polyclonal Antibody to Retinol Binding Protein 2, Cellular (RBP2)
kl377Mu01 视黄醇结合蛋白2(RBP2)多克隆抗体 Polyclonal Antibody to Retinol Binding Protein 2, Cellular (RBP2)
kl377Ra01 视黄醇结合蛋白2(RBP2)多克隆抗体 Polyclonal Antibody to Retinol Binding Protein 2, Cellular (RBP2)
kl400Hu01 视黄醇结合蛋白1(RBP1)多克隆抗体 Polyclonal Antibody to Retinol Binding Protein 1, Cellular (RBP1)
